Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Durata Therapeutics (DRTX)

Add to Watchlists
Create an Alert
13.44 +0.15  +1.13% NASDAQ Apr 24, 10:50AM BATS Real time Currency in USD
View Full Chart
DRTX Price Chart
View All Events

DRTX Events

Date Type Description
Mar 14 Misc Durata Therapeutics Inc Q4 2013 Earning Conference Call
Mar 14 Earnings Durata Therapeutics Inc Q4 2013 Earning Result. Estimate: -0.69.
Nov 06 Misc Q3 2013 Financial Results Conference Call November 6, 2013 at 8:30 Am Et
Nov 06 Earnings Third Quarter 2013 Financial Results on November 6, 2013. Estimate: -0.60.
Aug 07 Misc Q2 2013 Financial Results Conference Call August 7, 2013 at 8:30 Am Et
Aug 07 Earnings Durata Therapeutics to Announce Second Quarter 2013 Financial Results on August 7, 2013. Estimate: -0.42.
May 09 Misc Q1 2013 Financial Results Conference Call
May 09 Earnings Durata Therapeutics to Announce First Quarter 2013 Financial Results on May 9, 2013. Estimate: -0.73.
View All Performance Charts

DRTX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Durata Therapeutics is up 74.55% over the last year vs S&P 500 Total Return up 21.37%, Cubist Pharmaceuticals up 41.06%, and Alexion Pharmaceuticals up 71.33%.

Get Quote for
Advertisement

Portfolio Strategies Featuring DRTX

Did Durata Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

DRTX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Illinois
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Durata Therapeutics Inc is a clinical development stage biopharmaceutical company. The Company develops and commercializes novel therapeutics for patients with infectious diseases and acute illnesses.

Recent Quotes

Symbol Price Chg Chg % Market Cap
DRTX 13.44 +0.15 +1.13% 358.05M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.